No serious adverse reactions were detected, which allows to conclude that the vaccination is safe.
According to the official website of the mayor and government, in Moscow, more than half of the participants in a study of the COVID-19 vaccine for adolescents were vaccinated with the first component of the vaccine. Preliminary results showed the safety of the vaccine and no serious adverse reactions were detected in those vaccinated.
According to information from Ismail Osmanov, chief pediatrician of the Moscow City Health Department, the third phase of clinical trial of COVID-vaccine for teenagers was launched in November 2021 on the basis of two children's hospitals and 10 Moscow outpatient clinics.
At present, half of the planned work has been done - more than 1.5 thousand adolescents received the first component of the vaccine, and more than 1.2 thousand were vaccinated with two. All the time the trial participants keep a health diary in a mobile application, and doctors monitor their condition.